Bliss GVS Pharma’s stock rose 4% in morning trade after the company received a GMP (Good Manufacturing Practice) Compliance Certificate. This certification was granted after a rigorous inspection by Romania’s National Agency for Medicines and Medical Devices (NAMMDR) on November 30 and December 1, 2023.
The inspection covered the company’s state-of-the-art manufacturing facilities at Dewan Udyog Nagar and Vevoor Village in Palghar, Maharashtra. This milestone underscores the company’s commitment to quality and international compliance standards.
Stock performance:
- Open: ₹135.00
- High: ₹138.36
- Low: ₹132.05
As of 9:32 am, Bliss GVS Pharma shares were trading 4.72% higher at Rs 137.76 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
